Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

Ítems similars

• Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells
  per: Wang, Yue-qin, et al.
  Publicat: (2016)
• FS-93, an Hsp90 inhibitor, induces G2/M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cells
  per: Zhang, Liping, et al.
  Publicat: (2015)
• Circumventing HSP90 inhibitors via apoptosis block
  per: Fennell, Dean A., et al.
  Publicat: (2015)
• Histone Deacetylase Inhibitors Interrupt HSP90•RASGRP1 and HSP90•CRAF Interactions to Upregulate BIM and Circumvent Drug Resistance in Lymphoma Cells
  per: Ding, Husheng, et al.
  Publicat: (2016)
• Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer
  per: Mao, Jianhua, et al.
  Publicat: (2018)